Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 15, 1996
Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes
M L Grimes, J Zhou, E C Beattie, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 16, 2001
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion
J D Cooper, A Salehi, J D Delcroix, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 12, 1996
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
D M Holtzman, D Santucci, J Kilbridge, et al.
Neurobiology of Disease
|
October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]
H M Mitchison, D J Bernard, N D Greene, et al.
British Journal of Anaesthesia
|
March 27, 2018
Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits
M L Pearn, J M Schilling, M Jian, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 15, 1996
Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes
M L Grimes, J Zhou, E C Beattie, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 16, 2001
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion
J D Cooper, A Salehi, J D Delcroix, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 12, 1996
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
D M Holtzman, D Santucci, J Kilbridge, et al.
Neurobiology of Disease
|
October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]
H M Mitchison, D J Bernard, N D Greene, et al.
British Journal of Anaesthesia
|
March 27, 2018
Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits
M L Pearn, J M Schilling, M Jian, et al.
Page
of 8